isoxazoles has been researched along with Diffuse Parenchymal Lung Disease in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 20 (66.67) | 29.6817 |
| 2010's | 10 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atzeni, F; Benucci, M; Boiardi, L; Sallì, S; Sarzi-Puttini, P | 1 |
| Arstila, L; Elfving, P; Kaipiainen-Seppänen, O; Kononoff, A; Koskela, H; Rutanen, J | 1 |
| Chazan, R; Karwat, K; Langfort, R; Maskey-Warzęchowska, M; Szczepankiewicz, B; Szołkowska, M | 1 |
| Chung, KP; Huang, HN; Keng, LT; Lin, MW | 1 |
| Jia, Y; Miao, H; Wang, L; Yang, Y; Zhang, XY; Zhou, YS | 1 |
| Champion, HC; Girgis, RE; Hassoun, PM; Hummers, LK; Mathai, SC; Wigley, FM; Zaiman, A | 1 |
| Chikura, B; Dawson, JK; Lane, S | 1 |
| Inokuma, S; Matsuda, T; Otsuka, T; Saeki, Y; Sagawa, A; Sato, T; Sawada, T; Takemura, T; Takeuchi, T | 2 |
| Alcorn, N; Madhok, R; Saunders, S | 1 |
| Chu, CM; Kan, CH; Ng, WL; Tsui, HS; Wong, SP | 1 |
| Hutchinson, DG; Lee, MA | 1 |
| Dawson, JK; McLaren, ZL | 1 |
| Zhang, WX; Zhang, ZQ; Zhao, XW; Zhou, W | 1 |
| Inokuma, S | 1 |
| Jacobi, AM; Mohr, M | 1 |
| McCurry, J | 1 |
| Scott, DL | 1 |
| Ito, S; Sumida, T | 1 |
| Haneda, K; Iwamoto, M; Kamata, Y; Kamimura, T; Masuyama, J; Minota, S; Nara, H; Okazaki, H | 1 |
| Nakajima, A; Yamanaka, H | 1 |
| Sugii, S | 1 |
| Adachi, D; Akiba, H; Akiyama, Y; Hirano, M; Mimura, T; Takeishi, M | 1 |
| Ernst, P; Hudson, M; Suissa, S | 1 |
| Kudo, S | 1 |
| Chida, K; Miyazaki, K; Ogura, T; Sugiyama, Y; Yamaguchi, T | 1 |
| Hagiyama, H; Harigai, M; Iwai, H; Miyasaka, N; Mizoguchi, F; Ochi, S; Oka, T | 1 |
| Doi, T; Kato, T; Nikaido, K; Takayama, R | 1 |
| Choe, JY; Chung, SH; Ju, JH; Kim, HY; Kim, SI; Lee, J; Lee, JH; Lee, SI; Lee, SS; Lee, YH; Park, SH; Yoo, WH; Yoon, CH; Yoon, HJ | 1 |
| Harada, M; Inokuma, S; Koyama, T; Niiro, H; Ohtani, R; Otsuka, T; Yoshizawa, S | 1 |
8 review(s) available for isoxazoles and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis.
Topics: Antibodies, Blocking; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Methotrexate; Patient Education as Topic; Rituximab; Tumor Necrosis Factor-alpha | 2013 |
Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment: A Case Report and Literature Review.
Topics: Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Pulmonary Alveoli; Time Factors | 2016 |
Clinical expression of leflunomide-induced pneumonitis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Pneumonia; Retrospective Studies; Tomography, X-Ray Computed | 2009 |
Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Interactions; Drug Therapy, Combination; Humans; Isoxazoles; Leflunomide; Liver; Lung Diseases, Interstitial; Risk Assessment | 2009 |
Leflunomide-induced interstitial pneumonitis might be a representative of disease-modifying antirheumatic drug-induced lung injury.
Topics: Animals; Antirheumatic Agents; Humans; Isoxazoles; Japan; Leflunomide; Lung Diseases, Interstitial; Lung Injury; Radiography | 2011 |
[Leflunomide for therapy of rheumatoid arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topic; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Matrix Metalloproteinases; Oxidoreductases; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2005 |
[Adverse effects of DMARDs in treatment of rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Gold Sodium Thiomalate; Hematologic Diseases; Humans; Isoxazoles; Kidney Diseases; Leflunomide; Lung Diseases, Interstitial; Male; Methotrexate; Reproduction; Sulfasalazine | 2005 |
[Drug induced lung injuries in Japanese population].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Asian People; Bleomycin; Gefitinib; Genetic Predisposition to Disease; Humans; Isoxazoles; Japan; Leflunomide; Lung Diseases, Interstitial; Pulmonary Alveoli; Quinazolines; Racial Groups | 2006 |
22 other study(ies) available for isoxazoles and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Five cases of interstitial lung disease after leflunomide was combined with methotrexate therapy.
Topics: Aged; Arthritis, Rheumatoid; Disease Progression; Drug Interactions; Drug Therapy, Combination; Female; Finland; Humans; Incidence; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Prognosis; Risk Assessment; Sampling Studies; Survival Rate | 2014 |
Leflunomide-induced acute interstitial pneumonia in a patient treated for rheumatoid arthritis.
Topics: Adjuvants, Immunologic; Arthritis, Rheumatoid; Fatal Outcome; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Male; Middle Aged; Radiography, Thoracic | 2015 |
[Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Arthritis; Cyclophosphamide; Disease Progression; Female; Hematologic Diseases; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Pain; Prognosis; Raynaud Disease; Recurrence; Scleritis; Serositis; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vision Disorders | 2016 |
Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
Topics: Bosentan; Cohort Studies; Comorbidity; Endothelin Receptor Antagonists; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Isoxazoles; Lung Diseases, Interstitial; Male; Maryland; Middle Aged; Piperazines; Prognosis; Proportional Hazards Models; Purines; Receptors, Endothelin; Scleroderma, Diffuse; Scleroderma, Systemic; Sildenafil Citrate; Sulfonamides; Sulfones; Survival Rate; Thiophenes; Vasodilator Agents | 2009 |
Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Body Weight; Female; Humans; Isoxazoles; Japan; Leflunomide; Lung Diseases, Interstitial; Male; Middle Aged; Prevalence; Product Surveillance, Postmarketing; Risk Factors; Smoking | 2009 |
Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis.
Topics: Aged; Aniline Compounds; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Crotonates; Female; Humans; Hydroxybutyrates; Hypoxia; Isoxazoles; Japan; Leflunomide; Lung Diseases, Interstitial; Lung Injury; Male; Middle Aged; Nitriles; Product Surveillance, Postmarketing; Prognosis; Respiration, Artificial; Risk Factors; Serum Albumin; Toluidines | 2009 |
Successful treatment of leflunomide-induced acute pneumonitis with cholestyramine wash-out therapy.
Topics: Adult; Alveolitis, Extrinsic Allergic; Anion Exchange Resins; Antirheumatic Agents; Arthritis, Rheumatoid; Cholestyramine Resin; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial | 2009 |
HRCT-proven leflunomide pneumonitis in a patient with psoriatic arthritis and normal lung function tests and chest radiography.
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Middle Aged; Radiographic Image Enhancement; Respiratory Function Tests; Tomography, X-Ray Computed | 2010 |
Comment on: Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Asian People; Cause of Death; Humans; Isoxazoles; Japan; Leflunomide; Lung Diseases, Interstitial; Lung Injury; Risk Factors | 2010 |
Interstitial lung diseases after leflunomide use in nephropathy: an analysis of reported cases in Chinese literature.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Child; China; Female; Humans; IgA Vasculitis; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Male; Middle Aged; Nephrotic Syndrome; Prognosis; Survival Rate; Young Adult | 2011 |
Interstitial lung disease in rheumatoid arthritis: response to IL-6R blockade.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; Dyspnea; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Methotrexate; Middle Aged; Peptides, Cyclic; Radiography; Receptors, Interleukin-6; Rheumatoid Factor; Steroids | 2011 |
Japan deaths spark concerns over arthritis drug.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cause of Death; Drug Approval; Humans; Isoxazoles; Japan; Leflunomide; Lung Diseases, Interstitial; Treatment Outcome | 2004 |
Interstitial lung disease and disease modifying anti-rheumatic drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial | 2004 |
Interstitial lung disease associated with leflunomide.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial | 2004 |
Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Eruptions; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Male; Middle Aged | 2004 |
Leflunomide induced acute interstitial pneumonia.
Topics: Adjuvants, Immunologic; Arthritis, Rheumatoid; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Middle Aged; Prednisolone; Radiography, Thoracic; Treatment Outcome | 2005 |
Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Male; Middle Aged; Risk Factors | 2006 |
[Diagnosis of and therapy for diffuse lung diseases (discussion)].
Topics: Alveolitis, Extrinsic Allergic; Biomarkers; Bronchiolitis; Gefitinib; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Quinazolines; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed | 2006 |
Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis: autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage.
Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Autopsy; Cholestyramine Resin; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Methylprednisolone; Pulmonary Alveoli; Tomography, X-Ray Computed | 2006 |
[Valproate sodium and zonisamide associated interstitial pneumonitis in an infant].
Topics: Anticonvulsants; Epilepsy; Female; Humans; Infant; Isoxazoles; Lung Diseases, Interstitial; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Spasms, Infantile; Valproic Acid; Zonisamide | 2007 |
Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Korea; Leflunomide; Lung Diseases, Interstitial; Male; Middle Aged; Risk Factors | 2007 |
Leflunomide-induced lung injury that developed after its withdrawal, coinciding with peripheral blood lymphocyte count decrease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Administration Schedule; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Lymphocyte Count; Middle Aged; Pulmonary Fibrosis | 2008 |